Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Initiation of phase IV trial of Periostat and Atridox combination therapy

Jan. 9, 2003

Expanded indication for EmdogainGel in E.U.

Nov. 27, 2002

Atridox to be studied in chronic periodontitis/heart disease trial

July 16, 2002

FDA approves pivotal periodontal surgery trial of dermal substitute

July 11, 2002

Selective Lys-gingipain inhibitors for use in periodontitis

July 3, 2002

Periostat receives final marketing approvals in Portugal and The Netherlands

July 2, 2002

Platelet-derived growth factor evaluated in periodontal disease

May 31, 2002

Periostat approved in Israel

May 8, 2002

Periostat approved in Austria and Finland

April 26, 2002

MMP inhibitors with activity in animal model of periodontitis

April 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...